Histidine‐rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease
Matthias Bartneck(DWI – Leibniz Institute for Interactive Materials), Frank Tacke(Charité - Universitätsmedizin Berlin), Willi Jahnen‐Dechent(RWTH Aachen University), Olivier Govaere(VIB-KU Leuven Center for Microbiology), Josef Ehling(RWTH Aachen University), Klaudia Theresa Warzecha(Universitätsklinikum Aachen), Tom Luedde(Heinrich Heine University Düsseldorf), Tania Roskams(KU Leuven), Viktor Fech(Universitätsklinikum Aachen), Twan Lammers(RWTH Aachen University), Mihael Vucur(Düsseldorf University Hospital), Kanishka Hittatiya(University of Bonn), Jérémie Gautheron(Inserm), Christian Trautwein(TUM Klinikum)
Cited by 103
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.4k
Tumor targeting via EPR: Strategies to enhance patient responses
|Advanced Drug Delivery Reviews|2018|1.2k
Smart cancer nanomedicine
|Nature Nanotechnology|2019|1.2k